CoChat

Pittsburgh Compound B (11C-PIB) and Fluorodeoxyglucose (18 F-FDG) PET in Patients With Alzheimer Disease, Mild Cognitive Impairment, and Healthy Controls

Open access
Devanand, D.P., Mikhno, Arthur, Pelton, Gregory H., Cuasay, Katrina, Pradhaban, Gnanavalli, Dileep Kumar, J.S., Upton, Neil, Lai, Robert, Gunn, Roger N., Libri, V., Xinhua Liu, van Heertum, Ronald, Mann, J. John, Parsey, Ramin V. · 2010 · Journal of Geriatric Psychiatry and Neurology
Cited by 107

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Abstract

Amyloid load in the brain using Pittsburgh compound B (11 C-PIB) positron emission tomography (PET) and cerebral glucose metabolism using fluorodeoxyglucose (18 F-FDG) PET were evaluated in patients with mild Alzheimer disease (AD, n = 18), mild cognitive impairment (MCI, n = 24), and controls (CTR, n = 18). 11 C-PIB binding potential (BP ND) was higher in prefrontal cortex, cingulate, parietal cortex, and precuneus in AD compared to CTR or MCI and in prefrontal cortex for MCI compared to CTR. For 18 F-FDG, regional cerebral metabolic rate for glucose (rCMRGlu) was decreased in precuneus and parietal cortex in AD compared to CTR and MCI, with no MCI—CTR differences. For the AD—CTR comparison, precuneus BP ND area under the receiver operating characteristic (ROC) curve (AUC) was 0.938 and parietal cortex rCMRGlu AUC was 0.915; for the combination, AUC was 0.989. 11 C-PIB PET BP ND clearly distinguished diagnostic groups and combined with 18 F-FDG PET rCMRGlu, this effect was stronger. These PET techniques provide complementary information in strongly distinguishing diagnostic groups in cross-sectional comparisons that need testing in longitudinal studies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/0891988710363715

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Cited by

See all 107

Metadata

Authors
Devanand, D. P., Mikhno, A., Pelton, G. H., Cuasay, K., Pradhaban, G., Dileep Kumar, J. S., Upton, N., Lai, R., Gunn, R. N., Libri, V., Liu, X., van Heertum, R., Mann, J. J., & Parsey, R. V.
Venue
Journal of Geriatric Psychiatry and Neurology
Published
2010-04-29
Volume
23
Issue
3
Pages
185-198
ISSN
  • 0891-9887 (ISSN-L)
  • 1552-5708
OpenAlex
W2062210296
Cited by
107
References
13
FWCI
8.97
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Pittsburgh Compound B (11C-PIB) and Fluorodeoxyglucose (18 F-FDG) PET in Patients With Alzheimer Disease, Mild Cognitive Impairment, and Healthy Controls. https://app.cochat.ai/papers/10.1177/0891988710363715
The paper
Devanand, D. P., Mikhno, A., Pelton, G. H., Cuasay, K., Pradhaban, G., Dileep Kumar, J. S., Upton, N., Lai, R., Gunn, R. N., Libri, V., Liu, X., van Heertum, R., Mann, J. J., & Parsey, R. V. (2010). Pittsburgh Compound B (11C-PIB) and Fluorodeoxyglucose (18 F-FDG) PET in Patients With Alzheimer Disease, Mild Cognitive Impairment, and Healthy Controls. Journal of Geriatric Psychiatry and Neurology. https://doi.org/10.1177/0891988710363715

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.